Research output per year
Research output per year
BSc (Pharm), PhD
BS8 1TD
The Koh Laboratory is interested in exploring and exploiting molecular aberrations in cancer. Through collaborative use of omics profiling, imaging, molecular biology, pharmacology and computational approaches, we study how deregulated biological pathways, such as the DNA Damage Response and RAS signalling network, mediate tumour proliferation and progression. We leverage these mechanistic insights to identify actionable cancer-specific vulnerabilities. Our goal is to develop selective, synergistic treatment strategies that enable maximal tumour-cell killing and minimal host toxicity.
Enquiries from prospective graduate students and postdoctoral researchers are welcome.
Harvard Medical School, Massachusetts General Hospital
National University of Singapore
University of Cambridge
Research output: Contribution to journal › Article (Academic Journal) › peer-review
Research output: Contribution to journal › Article (Academic Journal)
Research output: Contribution to journal › Review article (Academic Journal) › peer-review